These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 26891932)

  • 1. Theranostic Nanomedicine; A Next Generation Platform for Cancer Diagnosis and Therapy.
    Sharma R; Mody N; Agrawal U; Vyas SP
    Mini Rev Med Chem; 2017; 17(18):1746-1757. PubMed ID: 26891932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium theranostics for the diagnosis and treatment of cancer.
    Robertson AG; Rendina LM
    Chem Soc Rev; 2021 Apr; 50(7):4231-4244. PubMed ID: 33599224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis.
    Kundu P; Singh D; Singh A; Sahoo SK
    Anticancer Agents Med Chem; 2020; 20(11):1288-1299. PubMed ID: 31429694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Potential of Targeted Nanoparticles for Brain Cancer.
    Bhatt A; Gurnany E; Modi A; Gulbake A; Jain A
    Mini Rev Med Chem; 2017; 17(18):1758-1777. PubMed ID: 28969541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic nanoparticles for precision oncology: theranostic magnetic iron oxide nanoparticles for image-guided and targeted cancer therapy.
    Zhu L; Zhou Z; Mao H; Yang L
    Nanomedicine (Lond); 2017 Jan; 12(1):73-87. PubMed ID: 27876448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal nanoparticles: a theranostic nanotool against cancer.
    Sharma H; Mishra PK; Talegaonkar S; Vaidya B
    Drug Discov Today; 2015 Sep; 20(9):1143-51. PubMed ID: 26007605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy.
    Rhee JK; Park OK; Lee A; Yang DH; Park K
    Mar Drugs; 2014 Dec; 12(12):6038-57. PubMed ID: 25522316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic applications of nanoparticles in cancer.
    Ahmed N; Fessi H; Elaissari A
    Drug Discov Today; 2012 Sep; 17(17-18):928-34. PubMed ID: 22484464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voyage of theranostic liposomes for imaging and therapy.
    Sachin M; Sachin D; Dinesh S
    J Cosmet Laser Ther; 2017 Aug; 19(4):245-249. PubMed ID: 28135901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic lipid nanoparticles for cancer medicine.
    Charron DM; Chen J; Zheng G
    Cancer Treat Res; 2015; 166():103-27. PubMed ID: 25895866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
    Mohammadi M; Ramezani M; Abnous K; Alibolandi M
    Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer nanotheranostics: Strategies, promises and impediments.
    Roy Chowdhury M; Schumann C; Bhakta-Guha D; Guha G
    Biomed Pharmacother; 2016 Dec; 84():291-304. PubMed ID: 27665475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small conjugate-based theranostic agents: an encouraging approach for cancer therapy.
    Kumar R; Shin WS; Sunwoo K; Kim WY; Koo S; Bhuniya S; Kim JS
    Chem Soc Rev; 2015 Oct; 44(19):6670-83. PubMed ID: 26118960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-in-One Nanomedicine: Multifunctional Single-Component Nanoparticles for Cancer Theranostics.
    Cai Y; Chen X; Si J; Mou X; Dong X
    Small; 2021 Dec; 17(52):e2103072. PubMed ID: 34561968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A challenge for theranostics: is the optimal particle for therapy also optimal for diagnostics?
    Dreifuss T; Betzer O; Shilo M; Popovtzer A; Motiei M; Popovtzer R
    Nanoscale; 2015 Oct; 7(37):15175-84. PubMed ID: 26313344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
    Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
    Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.